130 related articles for article (PubMed ID: 26964005)
1. Protective Effects of Colivelin Against Alzheimer's Disease in a PDAPP Mouse Model.
Yin R; Yin K; Guo Z; Zhang Z; Chen L; Cao L; Li Y; Wei Y; Fu X; Shi X
Cell Physiol Biochem; 2016; 38(3):1138-46. PubMed ID: 26964005
[TBL] [Abstract][Full Text] [Related]
2. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
[TBL] [Abstract][Full Text] [Related]
3. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease.
Yamada M; Chiba T; Sasabe J; Terashita K; Aiso S; Matsuoka M
Neuropsychopharmacology; 2008 Jul; 33(8):2020-32. PubMed ID: 17928813
[TBL] [Abstract][Full Text] [Related]
4. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo.
Chiba T; Yamada M; Hashimoto Y; Sato M; Sasabe J; Kita Y; Terashita K; Aiso S; Nishimoto I; Matsuoka M
J Neurosci; 2005 Nov; 25(44):10252-61. PubMed ID: 16267233
[TBL] [Abstract][Full Text] [Related]
5. Colivelin ameliorates amyloid β peptide-induced impairments in spatial memory, synaptic plasticity, and calcium homeostasis in rats.
Wu MN; Zhou LW; Wang ZJ; Han WN; Zhang J; Liu XJ; Tong JQ; Qi JS
Hippocampus; 2015 Mar; 25(3):363-72. PubMed ID: 25332198
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
8. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
9. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
10. A humanin derivative reduces amyloid beta accumulation and ameliorates memory deficit in triple transgenic mice.
Niikura T; Sidahmed E; Hirata-Fukae C; Aisen PS; Matsuoka Y
PLoS One; 2011 Jan; 6(1):e16259. PubMed ID: 21264226
[TBL] [Abstract][Full Text] [Related]
11. Nicotine exerts neuroprotective effects against β-amyloid-induced neurotoxicity in SH-SY5Y cells through the Erk1/2-p38-JNK-dependent signaling pathway.
Xue MQ; Liu XX; Zhang YL; Gao FG
Int J Mol Med; 2014 Apr; 33(4):925-33. PubMed ID: 24481039
[TBL] [Abstract][Full Text] [Related]
12. [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats.
Yuan L; Liu XJ; Han WN; Li QS; Wang ZJ; Wu MN; Yang W; Qi JS
Neurosci Bull; 2016 Aug; 32(4):374-82. PubMed ID: 27306655
[TBL] [Abstract][Full Text] [Related]
13. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
14. Ameliorating Activity of Ishige okamurae on the Amyloid Beta-Induced Cognitive Deficits and Neurotoxicity through Regulating ERK, p38 MAPK, and JNK Signaling in Alzheimer's Disease-Like Mice Model.
Kwon OY; Lee SH
Mol Nutr Food Res; 2020 Jun; 64(12):e1901220. PubMed ID: 32437593
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of CPCGI on Alzheimer's disease and its mechanism.
Wang X; Zhao J
Mol Med Rep; 2020 Jan; 21(1):115-122. PubMed ID: 31939621
[TBL] [Abstract][Full Text] [Related]
16. Shenzao jiannao oral liquid, an herbal formula, ameliorates cognitive impairments by rescuing neuronal death and triggering endogenous neurogenesis in AD-like mice induced by a combination of Aβ42 and scopolamine.
Xiao H; Li H; Song H; Kong L; Yan X; Li Y; Deng Y; Tai H; Wu Y; Ni Y; Li W; Chen J; Yang J
J Ethnopharmacol; 2020 Sep; 259():112957. PubMed ID: 32416248
[TBL] [Abstract][Full Text] [Related]
17. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
18. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer's Disease.
Wang X; Wang Y; Zhu Y; Yan L; Zhao L
Drug Des Devel Ther; 2019; 13():4053-4063. PubMed ID: 31819374
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
